| Product NDC: | 60505-1325 |
| Proprietary Name: | Midodrine Hydrochloride |
| Non Proprietary Name: | midodrine hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; midodrine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-1325 |
| Labeler Name: | Apotex Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077746 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060912 |
| Package NDC: | 60505-1325-3 |
| Package Description: | 30 TABLET in 1 BOTTLE (60505-1325-3) |
| NDC Code | 60505-1325-3 |
| Proprietary Name | Midodrine Hydrochloride |
| Package Description | 30 TABLET in 1 BOTTLE (60505-1325-3) |
| Product NDC | 60505-1325 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | midodrine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060912 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp |
| Substance Name | MIDODRINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |